JD Health International Inc.

6618

KYG5074A1004

Drug Retailers

Market Closed - Hong Kong S.E. Other stock markets 16:08:09 13/06/2025 HKT			5-day change	1st Jan Change
40.70 ^HKD	-2.05%		+2.78%	+44.84%

06-11	Jefferies Adjusts JD Health International's Price Target to HK$60 From HK$46, Keeps at Buy	MT
06-03	China, HK shares rise as banks and carmakers rally; trade talks eyed	RE

Nomura Adjusts JD Health International's Price Target to HK$44 From HK$41.50, Keeps at Buy

Published on 15/05/2025 at 17:39

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about JD Health International Inc.

Jefferies Adjusts JD Health International's Price Target to HK$60 From HK$46, Keeps at Buy	06-11	MT
China, HK shares rise as banks and carmakers rally; trade talks eyed	06-03	RE
Nomura Adjusts JD Health International's Price Target to HK$44 From HK$41.50, Keeps at Buy	05-15	MT
JD Health International's Profit Jumps 4.6% in Q1	05-13	MT
JD Health International Posts Q1 Revenue Of RMB16.65 Billion	05-13	RE
Nomura Adjusts JD Health International's Price Target to HK$41.50 From HK$31, Keeps at Buy	03-10	MT
JD Health International Inc. Provides Revenue Guidance for the Year 2025	03-06	CI
JD Health International Inc., 2024 Earnings Call, Mar 06, 2025	03-06
JD Health International Logs 94% Higher Attributable Profit for 2024	03-06	MT
JD Health International Posts FY Revenue Of RMB 58,200 Million	03-06	RE
JD Health International Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	03-06	CI
DeepSeek, Tariff Relief Drive Rally in Chinese Tech Stocks	02-14	DJ
Nomura Adjusts JD Health International's Price Target to HK$31 From HK$25, Keeps at Buy	11-18	MT
JD Health International Records 212% Higher Profit, 15% Higher Revenue for Q3	11-14	MT
JD Health International Grants Share Awards Under Post-IPO Award Scheme	02/10/24	MT
Nomura Adjusts JD Health International's Price Target to HK$25 From HK$37, Keeps at Buy	19/08/24	MT
Hong Kong Stocks Extend Gains on US Rate Cut Hopes; Holly Futures Jumps 15%	19/08/24	MT
HK stocks drift higher on US rate outlook; China banks hit record peaks	19/08/24	RE
HK stocks drift higher on US rate outlook; China banks hit record peaks	19/08/24	RE
JD Health International Inc. Reports Earnings Results for the Half Year Ended June 30, 2024	15/08/24	CI
JD Health's H1 Profit Surges to 2 Billion Yuan	15/08/24	MT
JD Health International Inc., H1 2024 Earnings Call, Aug 15, 2024	15/08/24
JD Health International Inc. Announces Appointment of Professor George Lau as Independent Non-Executive Director	15/08/24	CI
Morgan Stanley Downgrades JD Health International to Underweight From Equal-weight; Price Target is HK$20.40	17/07/24	MT
JD.com's Healthcare Arm Shuttering Family Doctor Initiative	29/05/24	MT

Chart JD Health International Inc.

Duration

Period

6618: Dynamic Chart

JD Health International Inc is a China-based investment holding company principally engaged in the Internet + Healthcare ecosystem business. The Company mainly providing pharmaceutical and healthcare products and Internet healthcare, health management, intelligent healthcare solutions to the customers, as well as a variety of marketing services to the business partners. The Company mainly conducts its businesses in domestic market.

Employees

3,564

Sector

Drug Retailers

Calendar

08-26 - Q2 2025 Earnings Release (Projected)

More about the company